Thu, 14 Jan 2010 13:43:07 -0500 PVI, PeerView Institute for Medical Education http://www.peerviewpress.com Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker Thought leader perspectives on current clinical advances in medicine PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. 2006 PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://media.peerviewpress.com/000136/podcast/pvi/xml/podcast_PulmonologyCME-CNE-CPE_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Pulmonology no PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/Audio_Podcast_Audio_PPVNE06250.mp3 Thu, 10 Dec 2009 10:43:46 -0500 Science, Medicine no 00:30:16 NSCLC, lung cancer, maintenance, pemetrexed, cetuximab, erlotinib, targeted, cytotoxic, JMEN, treatment break PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06250CMEinfo.pdf Thu, 10 Dec 2009 10:43:24 -0500 Science, Medicine no 00:00:00 NSCLC, lung cancer, maintenance, pemetrexed, cetuximab, erlotinib, targeted, cytotoxic, JMEN, treatment break PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, an expert in non–small-cell lung cancer (NSCLC) discusses the rationale for studying maintenance therapy in NSCLC settings and the clinical implications of new data on the maintenance use of active cytotoxic agents and targeted therapy in patients with advanced NSCLC. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE05904r67.mp3 Fri, 25 Sep 2009 14:51:18 -0400 Science, Medicine no 00:14:52 maintenance, NSCLC, lung cancer, cytotoxic, JMEN, Fidias, nonsquamous, squamous, histology, erlotinib, advanced PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE05904CMEinfo.pdf Fri, 25 Sep 2009 14:51:15 -0400 Science, Medicine no 00:00:00 maintenance, NSCLC, lung cancer, cytotoxic, JMEN, Fidias, nonsquamous, squamous, histology, erlotinib, advanced PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts discuss the latest clinical trial data on the use of maintenance therapy, the clinical role of biomarkers in selecting the most appropriate therapy, and the potential of novel agents and combination strategies for advanced lung cancer. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PA05722FCs143.mp3 Tue, 08 Sep 2009 15:09:27 -0400 Science, Medicine no 00:34:29 NSCLC, lung cancer, histology, PFS, pemetrexed, nonsquamous, squamous, EGFR, JMEN, SATURN, Fidias PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PA05722FCCMEinfo.pdf Tue, 08 Sep 2009 15:09:26 -0400 Science, Medicine no 00:00:00 NSCLC, lung cancer, histology, PFS, pemetrexed, nonsquamous, squamous, EGFR, JMEN, SATURN, Fidias PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this educational activity, 3 clinical experts in NSCLC discuss the current state and potential future directions of targeted therapy for the treatment of this disease in its advanced stages. Highlights of this discussion include the integration of these therapies into first-line treatment and maintenance regimens for advanced NSCLC, emerging molecular targeted agents for recurrent/refractory disease, and the application of predictive and prognostic markers as well as other patient-specific and disease-related characteristics for treatment selection in patients with this malignancy. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PA05538FCe20.mp3 Tue, 11 Aug 2009 15:26:34 -0400 Science, Medicine no 00:34:43 non small cell lung cancer, NSCLC, gemcitabine, bevacizumab, cisplatin, pemetrexed, FLEX, erlotinib PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PA05538FCCMEinfo.pdf Tue, 11 Aug 2009 15:26:31 -0400 Science, Medicine no 00:00:00 non small cell lung cancer, NSCLC, gemcitabine, bevacizumab, cisplatin, pemetrexed, FLEX, erlotinib PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, an expert in PAH discusses signs and symptoms, diagnostic procedures, and optimal treatment approaches, including combination strategies, in patients with the condition. http://podcast.peerviewpress.com/Pulmonology/PA04897FCn210.mp3 http://media.peerviewpress.com/000136/podcast/pvi/mp3/PA04897FCn210.mp3 Wed, 17 Jun 2009 15:04:03 -0400 Science, Medicine no 00:24:23 pulmonary arterial hypertension, PAH PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PA04897FCCMEinfo.pdf Wed, 17 Jun 2009 15:04:01 -0400 Science, Medicine no 00:00:00 pulmonary arterial hypertension, PAH